Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
Developing broadly applicable neoantigen-directed adoptive cell therapies (ACTs) is challenging because each cancer patient has an unique neoantigen repertoire. Here, the authors present the crystal structures of tumor-specific T cell receptors (TCRs) that recognize a shared neoepitope arising from...
Main Authors: | Daichao Wu, D. Travis Gallagher, Ragul Gowthaman, Brian G. Pierce, Roy A. Mariuzza |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-16755-y |
Similar Items
-
Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
by: Roy A. Mariuzza, et al.
Published: (2023-11-01) -
Structural basis for recognition of cellular and viral ligands by NK cell receptors
by: Roy eMariuzza, et al.
Published: (2014-03-01) -
Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors
by: Daichao Wu, et al.
Published: (2022-01-01) -
Structural basis for self-discrimination by neoantigen-specific TCRs
by: John P. Finnigan, et al.
Published: (2024-03-01) -
Oligoclonal banding in MS.
by: Ebers, G
Published: (1984)